ANIP Latest Press Releases

-- October 23, 2026 --

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET Globe Newswire 6:55 AM

-- October 19, 2026 --

ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules Globe Newswire 6:55 AM

-- October 12, 2026 --

ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 Annual Meeting Globe Newswire 6:55 AM

-- September 30, 2026 --

ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting Globe Newswire 6:55 AM

-- September 23, 2026 --

ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension Globe Newswire 6:55 AM

-- September 3, 2026 --

ANI Pharmaceuticals to Present at September Investor Conferences Globe Newswire 6:55 AM

-- August 24, 2026 --

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors Globe Newswire 6:55 AM

-- August 7, 2026 --

ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results Globe Newswire 6:50 AM

-- July 24, 2026 --

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET Globe Newswire 6:50 AM

-- July 16, 2026 --

ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter Globe Newswire 4:34 PM

-- July 13, 2026 --

ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis Globe Newswire 6:50 AM

Market Data Delayed 15 Minutes